Filtered By:
Procedure: Angiography
Nutrition: Calcium

This page shows you your search results in order of date.

Order by Relevance | Date

Total 124 results found since Jan 2013.

Coronary artery disease grading by cardiac CT for predicting outcome in patients with stable angina
CONCLUSION: In patients referred for invasive angiography, a history of CHD was the strongest predictor of MACE. In patients without history of CHD, a coronary calcium score yielded at least equal risk stratification vs. more complex CHD grading.PMID:37541910 | DOI:10.1016/j.jcct.2023.07.004
Source: Atherosclerosis - August 4, 2023 Category: Cardiology Authors: Christian U Oeing Matthew B Matheson Mohammad R Ostovaneh Carlos E Rochitte Marcus Y Chen Burkert Pieske Klaus F Kofoed Joanne D Schuijf Hiroyuki Niinuma Marc Dewey Marcelo F di Carli Christopher Cox Jo ão A C Lima Armin Arbab-Zadeh Source Type: research

AI-Guided Quantitative Plaque Staging Predicts Long-Term Cardiovascular Outcomes in Patients at Risk for Atherosclerotic CVD
CONCLUSIONS: Through 10-year follow-up, AI-QCT plaque staging showed important prognostic value for MACE and showed additional discriminatory value over clinical risk factors, CACS, and manual guideline-recommended CCTA assessment.PMID:37480907 | DOI:10.1016/j.jcmg.2023.05.020
Source: Atherosclerosis - July 22, 2023 Category: Cardiology Authors: Nick S Nurmohamed Michiel J Bom Ruurt A Jukema Robin J de Groot Roel S Driessen Pepijn A van Diemen Ruben W de Winter Emilie L Gaillard Ralf W Sprengers Erik S G Stroes James K Min James P Earls Rhanderson Cardoso Ron Blankstein Ibrahim Danad Andrew D Cho Source Type: research

Atherosclerosis on CT coronary angiography and risk of long-term cardiovascular events post liver transplantation
CONCLUSION: The standardized CAD-RADS classification on CTCA predicted the occurrence of cardiovascular outcomes following LT, with a potential to increase utilization of preventive cardiovascular therapies.PMID:37432891 | DOI:10.1097/LVT.0000000000000215
Source: Atherosclerosis - July 11, 2023 Category: Cardiology Authors: Thalys Sampaio Rodrigues Anoop N Koshy Paul J Gow Laurence Weinberg Benjamin Cailes Adam Testro Gerard Smith Han S Lim Andrew W Teh Ruth P Lim Omar Farouque Source Type: research

Effect of Nicorandil, Diltiazem, or Isosorbide Mononitrate for Oral Antispastic Therapy After Coronary Artery Bypass Grafting Using Radial Artery Grafts —A Pilot Randomized Controlled Trial (ASRAB-Pilot): Rationale and Study Protocol
ConclusionThis pilot trial will compare the preliminary effects of nicorandil, diltiazem, and isosorbide mononitrate on angiographic and clinical outcomes in patients who have undergone RA-CABG. Recruitment began in June 2020, and the estimated primary completion date is early 2023. Results of this study will provide much needed information for design of large confirmatory trials on the effectiveness of oral antispastic medications after RA-CABG.
Source: Advances in Therapy - July 11, 2023 Category: Drugs & Pharmacology Source Type: research

Intracranial Spotty Calcium Predicts Recurrent Stroke in Patients with Symptomatic Intracranial Atherosclerotic Stenosis
ConclusionIn patients with symptomatic ICAS, intracranial spotty calcium is an independent predictor of recurrent ischemic stroke, which will further facilitate risk stratification and suggest that more aggressive treatment should be considered for these patients.
Source: Klinische Neuroradiologie - June 7, 2023 Category: Radiology Source Type: research

Effects of intensive lipid lowering compared with moderate-intensity lipid lowering on coronary atherosclerotic plaque phenotype and major adverse cardiovascular events in adults with low to intermediate 10-year ASCVD risk (ILLUMINATION study): protocol for a multicentre, open-label, blinded-endpoint, randomised controlled trial
Introduction Current guidelines recommend moderate-intensity lipid lowering (low-density lipoprotein cholesterol, LDL-C of <2.6 mmol/L or 30%–49% reduction from the baseline) for patients with intermediate 10-year atherosclerotic cardiovascular disease (ASCVD) risk. The effects of intensive lipid lowering (LDL-C of <1.8 mmol/L) on coronary atherosclerotic plaque phenotype and major adverse cardiovascular events (MACE) in adults with both non-obstructive coronary artery disease (CAD) and low to intermediate 10-year ASCVD risk remain uncertain. Methods and analysis Intensive Lipid-lowering for Plaque and Major A...
Source: BMJ Open - June 5, 2023 Category: General Medicine Authors: Zheng, J., Hou, Z., Yuan, J., Zhao, X., Wang, Y., Li, J., Zhang, W., Dou, K., Lu, B. Tags: Open access, Cardiovascular medicine Source Type: research

Quantitative CTA vascular calcification, atherosclerosis burden, and stroke mechanism in patients with ischemic stroke
CONCLUSION: Atherosclerosis calcium volumes in major vessels were significantly higher in LAA compared to non-LAA stroke in younger age.PMID:37148773 | DOI:10.1016/j.jns.2023.120667
Source: Atherosclerosis - May 6, 2023 Category: Cardiology Authors: Takashi Shimoyama Sibaji Gaj Kunio Nakamura Shivakrishna Kovi Shumei Man Ken Uchino Source Type: research

Intra-plaque calcium and its relation with the progression of carotid atheromatous disease
CONCLUSIONS: These results suggest that a higher content of Ca confers greater stability against the progression of carotid AD and, eventually, its ability to generate symptomatology.PMID:35583455 | DOI:10.23736/S0392-9590.22.04872-6
Source: International Angiology - May 18, 2022 Category: Cardiology Authors: Manuel Miralles Manel Arr ébola Aida Lago Sara Brugger Ra úl Lara Pilar Medina Albert Clar á Emma Plana Source Type: research